6Sun Ks, Oh SJ,Woo JT et al. Effect of cilostazol on the neumpathies of streptoeotocin - induced diabetic rats Korean J Intern Med, 1999,14(2) : 34 - 40.
7Ibrahim NK, Harris M, Radata et al. A new mininally invasive technique to show nerve I schaemia in diabetic neuropathy Diabetologian, 1999, (42) :737 - 742.
8Uehara K, Sugimoto K, Wada R, et al. Effects of cilostazo on the peripheral nerfve function and structure in STZ- induced diabeticrats J Thabetes Complications, 1997,11 : 194 - 202.
9Chiu S,Ritchie J. evidence for the presence of potassium channels in the paranodal region of acutely demyelinated mammalian single nerve fibers. J Physiol, 1981,313:415 -437.
10Bostock H, Sears T. The intemodal axon membrane: electrical excitability and continuous condiction in segmental demyelination. J Physiol, 1978,280 : 237 - 301.
4Vileikyte L,Peyrot M,Gonzalez JS. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy:a longitudinal study[J].Diabetologia,2009,(07):1265-1273.
5胡仁明;李益明;童伟.哈里森内分泌学[M]北京:人民卫生出版社,2010247-248.
6陈璐璐;曾天舒.内分泌科疑难问题解析[M]南京:江苏科学技术出版社,2009211.
7Ziegler D,Reljanovic M,Mehnert H. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany:current evidence from clinical trials[J].Exp Clin Endocr Diabetes,1999.421-430.
8Gouty S,Regalia J,Cai F. Alpha-lipoic acidtreatment prevevents the diabetes induced attenuation of the aferent limb of the baroreceptor reflex inrats[J].Auton Nerosci,2003,(02):32-44.
9Candrilli SD, Davis KL, Kan HJ, et al. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathyand diabetic retinopathy.J Diabetes Complications 2007,21 (5):306-314.
10Paul V, Claude LD, Jean LR, et al. A multicenter, double -blind safety study of QR - 333for the treatment of symptomatic diabetic peripheral neuropathy, apreliminary report[J].Diabetes Complications 2005;19(5):247-253.
